01-11-2004
Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors
Published in: Investigational New Drugs | Issue 4/2004
Login to get access01-11-2004
Published in: Investigational New Drugs | Issue 4/2004
Login to get access